Table 1.
Classification of lipid lowering regimens used by their LDL-C lowering efficacy
| Low % LDL-C reduction | Moderate % LDL-C reduction | High % LDL-C reduction | Very high % LDL-C reduction | |
|---|---|---|---|---|
|
Simvastatin |
10 mg |
10 mg + Eze |
|
40 mg + Eze |
| |
20 mg |
80 mg |
|
|
| |
|
20 mg + Eze |
80 mg + Eze |
|
| |
40 mg |
|
|
|
|
Fluvastatin |
40 mg |
80 mg |
|
|
| |
|
80 mg + Eze |
|
|
|
Rosuvastatin |
|
5 mg |
20 mg |
5 mg + Eze |
| |
|
|
10 mg + Eze |
|
| |
|
10 mg |
20 mg + Eze |
|
| |
|
|
40 mg |
|
| |
|
|
40 mg + E |
|
|
Pravastatin |
20 mg |
20 mg + Eze |
|
|
| 40 mg |
40 mg + Eze |
|
|
|
| |
80 mg |
|
|
|
|
Atorvastatin |
|
10 mg |
|
20 mg + Eze |
| |
20 mg |
40 mg |
40 mg + Eze |
|
| |
20 mg |
10 mg + Eze |
|
|
|
Ezetimibe |
10 mg |
|
|
|
| Fenofibrate | 200 mg |
Eze = ezetimibe.